Clinical Research Directory
Browse clinical research sites, groups, and studies.
BRIDGE-SIC Efficacy Trial
Sponsor: Dana-Farber Cancer Institute
Summary
This is a pragmatic, prospective, randomized clinical trial to test the effectiveness of large language model (LLM)-generated serious illness conversation (SIC) summaries delivered to patients' inpatient and outpatient clinicians at the time of hospital admission on the primary outcome of days in the hospital in the next 90 days.
Official title: Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication (BRIDGE-SIC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2026-07-31
Completion Date
2028-06-30
Last Updated
2026-07-30
Healthy Volunteers
No
Conditions
Interventions
LLM-generated SIC summary email to clinical teams
An email containing a summary of prior serious illness conversations, generated by a large language model, is sent to the patient's clinical teams at admission, prompting review and discussion of care preferences.
Locations (2)
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States